Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 13, 2023

BUY
$271.54 - $344.06 $998,724 - $1.27 Million
3,678 New
3,678 $1.27 Million
Q1 2022

May 12, 2022

SELL
$187.51 - $283.98 $460,337 - $697,170
-2,455 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$238.08 - $288.0 $5,713 - $6,912
24 Added 0.99%
2,455 $705,000
Q3 2021

Nov 02, 2021

BUY
$250.72 - $291.24 $8,524 - $9,902
34 Added 1.42%
2,431 $647,000
Q2 2021

Aug 10, 2021

BUY
$235.0 - $310.7 $563,295 - $744,747
2,397 New
2,397 $656,000
Q1 2021

May 07, 2021

SELL
$175.6 - $291.43 $219,324 - $363,996
-1,249 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$174.98 - $272.83 $218,550 - $340,764
1,249 New
1,249 $218,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $10.3B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.